FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway
Jiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu · 2024
Read FXR promotes clear cell renal cell carcinoma carcinogenesis via MMP-7-regulated EMT pathway by Jiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11599922.txt.
Description
Jiachen Liu and co-authors show in 2024 that a hormone sensor called FXR helps drive the most common kidney cancer. The sensor is better known for roles in gut tumors, where it often holds cancer back. In clear cell kidney cancer, the team found the opposite. Lab tests showed FXR binds directly to the switch of a gene called MMP-7. That gene feeds a program that lets cells change shape and spread.
In mouse tumors, the FXR-to-MMP-7 link shaped growth as expected. The result flips the usual view of FXR and opens a fresh treatment angle for this cancer. Blocking the pathway may slow the disease, the authors suggest.
Catalog record
| CREATOR | Jiachen Liu, Shiyu Huang, Yanguang Hou, Shujie Fu, Lei Wang, Juncheng Hu, Cheng Liu, Xiuheng Liu |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |